Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor

NCT01150903 · clinicaltrials.gov ↗

COMPLETED

Status

98832

Enrollment

INDUSTRY

Sponsor class

Conditions

Erectile Dysfunction
Cardiovascular Diseases
Male Urogenital Diseases

Interventions

OTHER: no intervention
OTHER: no intervention

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.